Çınarka, H. Et Al. 2014. The Clinical Utility of Serum YKL 40 Levels in Community Acquired Pneumonia. Advances in Bioscience and Clinical Medicine , vol.3, no.1 , 10-16.

Çınarka, H., GÜMÜŞ, A., KARATAŞ, M., KAYHAN, S., KIRBAŞ, A., ÖZYURT, S., ... KURT, A.(2014). The Clinical Utility of Serum YKL 40 Levels in Community Acquired Pneumonia. Advances in Bioscience and Clinical Medicine , vol.3, no.1, 10-16.

Çınarka, HALİT Et Al. "The Clinical Utility of Serum YKL 40 Levels in Community Acquired Pneumonia," Advances in Bioscience and Clinical Medicine , vol.3, no.1, 10-16, 2014

Çınarka, HALİT Et Al. "The Clinical Utility of Serum YKL 40 Levels in Community Acquired Pneumonia." Advances in Bioscience and Clinical Medicine , vol.3, no.1, pp.10-16, 2014

Çınarka, H. Et Al. (2014) . "The Clinical Utility of Serum YKL 40 Levels in Community Acquired Pneumonia." Advances in Bioscience and Clinical Medicine , vol.3, no.1, pp.10-16.

@article{article, author={HALİT ÇINARKA Et Al. }, title={The Clinical Utility of Serum YKL 40 Levels in Community Acquired Pneumonia}, journal={Advances in Bioscience and Clinical Medicine}, year=2014, pages={10-16} }